Mixed
Inulin supplementation reduces hepatic steatosis and adiposity in obese individuals only when specific bacterial genera (Barnesiella, Bilophila, Butyricimonas, Victivallis) are decreased and others (Clostridium XIVa, Raoultella, Blautia, Akkermansia) are increased.
This finding explains WHY some people lose fat on inulin and others don't. It's not just about taking the powder; it's about whether your gut bacteria can utilize it to produce beneficial metabolic changes. If your bacteria don't shift in the right way (e.g., increasing Akkermansia), you won't get the liver fat benefits.
among several bacterial genera, Barnesiella, Bilophila, Butyricimonas, Victivallis, Clostridium XIVa, Akkermansia, Raoultella and Blautia correlated with the observed metabolic outcomes (decrease in adiposity and hepatic steatosis) in hum- ob mice.
Why this rating
Supported by both human cohort data and humanized mouse models with rigorous statistical correlation (Spearman’s, PLS-DA).
Source
Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients
Julie Rodriguez et al. · Gut · 2020
DOI 10.1136/gutjnl-2019-319726
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →